Jagsonpal Pharmaceuticals Ltd vs Rajnish Wellness Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Jagsonpal Pharmaceuticals Ltd is ₹ 210.3 as of 30 Apr 15:30 . The P/E Ratio of Jagsonpal Pharmaceuticals Ltd changed from 12.2 on March 2021 to 25.9 on March 2025 . This represents a CAGR of 16.25% over 5 yearsThe P/E Ratio of Rajnish Wellness Ltd changed from 53.6 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 years The Market Cap of Jagsonpal Pharmaceuticals Ltd changed from ₹ 208.41 crore on March 2021 to ₹ 1433 crore on March 2025 . This represents a CAGR of 47.06% over 5 yearsThe Market Cap of Rajnish Wellness Ltd changed from ₹ 5.26 crore on March 2021 to ₹ 70.7 crore on March 2025 . This represents a CAGR of 68.15% over 5 years The revenue of Jagsonpal Pharmaceuticals Ltd for the Mar '26 is ₹ 67.37 crore as compare to the Dec '25 revenue of ₹ 75.92 crore. This represent the decline of -11.26% The revenue of Rajnish Wellness Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 23.61 crore. This represent the decline of -100% The ebitda of Jagsonpal Pharmaceuticals Ltd for the Mar '26 is ₹ 14.33 crore as compare to the Dec '25 ebitda of ₹ 17.16 crore. This represent the decline of -16.49% The ebitda of Rajnish Wellness Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ -1 crore. This represent the decline of -100% The net profit of Jagsonpal Pharmaceuticals Ltd changed from ₹ 5.33 crore to ₹ 8.76 crore over 8 quarters. This represents a CAGR of 28.20% The net profit of Rajnish Wellness Ltd changed from ₹ 0.17 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The Dividend Payout of Jagsonpal Pharmaceuticals Ltd changed from 15.36 % on March 2021 to 29.99 % on March 2025 . This represents a CAGR of 14.32% over 5 yearsThe Dividend Payout of Rajnish Wellness Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Jagsonpal Pharmaceuticals Ltd

Promoted by Rajpal Singh Kochhar in August, 1978, Jagsonpal Pharmaceuticals Limited is engaged in the manufacture and marketing bulk drugs and pharmaceuticals at its plant at Faridabad in Haryana.
The Company has adopted the strategy of clubbing all its products in seven groups for effective marketing and reducing costs.
Simultaneously, it has geared up to set up an ultra modern multi-purpose basic drugs and formulation plant through its subsidiary, Jagsonpal Exports India Pvt Ltd. The company has a strategic alliance with Fidia Spa, Italy; and B Spofola, Czechoslovakia; to manufacture sophisticated drugs in India.
It has tied up with another Israel-based company, Makhteshim Chemical Works, for acquiring the marketing rights of an anti-oxidant product.
In 1994, the company has also promoted Aresco Financial Services, a new financial company.

About Rajnish Wellness Ltd

Rajnish Wellness Limited was originally incorporated on June 13, 2015 as a Private Limited Company under the name and style of 'Rajnish Hot Deals Private Limited'.
Subsequently, the Company was converted into a Public Limited Company on February 01, 2018 and was renamed to 'Rajnish Wellness Limited' on February 09, 2018. The Company is currently engaged in the business of selling various products in the categories ranging from consumer durables to ayurvedic personal care products.
The Company's major focus area is sexual wellness, energy revitalization and personal care products.
Changing lifestyle and awareness of health and wellness is increasing demand for sexual wellness and energy revitalization products.
Current product portfolio is concentratedon ayuvedic products.

FAQs for the comparison of Jagsonpal Pharmaceuticals Ltd and Rajnish Wellness Ltd

Which company has a larger market capitalization, Jagsonpal Pharmaceuticals Ltd or Rajnish Wellness Ltd?

Market cap of Jagsonpal Pharmaceuticals Ltd is 1,411 Cr while Market cap of Rajnish Wellness Ltd is 50 Cr

What are the key factors driving the stock performance of Jagsonpal Pharmaceuticals Ltd and Rajnish Wellness Ltd?

The stock performance of Jagsonpal Pharmaceuticals Ltd and Rajnish Wellness Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Jagsonpal Pharmaceuticals Ltd and Rajnish Wellness Ltd?

As of May 4, 2026, the Jagsonpal Pharmaceuticals Ltd stock price is INR ₹210.3. On the other hand, Rajnish Wellness Ltd stock price is INR ₹0.5.

How do dividend payouts of Jagsonpal Pharmaceuticals Ltd and Rajnish Wellness Ltd compare?

To compare the dividend payouts of Jagsonpal Pharmaceuticals Ltd and Rajnish Wellness Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.